Skip to Content

Join the 'Disruptive Mood Dysregulation Disorder' group to help and get support from people like you.

Disruptive Mood Dysregulation Disorder News

Demi Lovato Wants to Change the Face of Mental Illness

Posted 7 days ago by Drugs.com

WEDNESDAY, Nov. 30, 2016 – Since her 2008 breakthrough role in the Disney Channel musical "Camp Rock," singer and actress Demi Lovato has released five best-selling albums and a slew of hit singles. Numerous music awards have followed, as has a stint as a judge on the TV megahit "The X Factor." But for the 44 million American adults struggling with mental illness, it's the 24-year-old's decision to share her own mental health battles that may rank as her most meaningful achievement to date. "I've been very, very open about my story," said Lovato. "I was diagnosed when I was 18 with bipolar disorder," a condition shared by roughly 13 million Americans. "And ever since, I've been doing whatever I could to raise awareness about mental illness, and mental health, in America." Since 2015, Lovato has served as the public face of the "Be Vocal" initiative. It's a campaign that brings together ... Read more

Related support groups: Depression, Bipolar Disorder, Lexapro, Zoloft, Wellbutrin, Cymbalta, Effexor, Prozac, Celexa, Citalopram, Paxil, Major Depressive Disorder, Sertraline, Pristiq, Bupropion, Amitriptyline, Fluoxetine, Viibryd, Venlafaxine, Effexor XR

Troubled Preschoolers Not Getting Effective Treatment: Report

Posted 16 days ago by Drugs.com

MONDAY, Nov. 21, 2016 – Most preschoolers with mood, behavior and social disorders would benefit from non-drug therapies, but few receive this type of help, a leading group of U.S. pediatricians reports. As many as one in 10 kids younger than 5 years old experiences these kinds of mental health problems, the American Academy of Pediatrics said in a new report. Current evidence supports the use of "family-focused" therapies – often including parent training – as a first-line treatment for these children, the AAP reported. Yet mental health stigma, shortages of trained providers and insurance barriers limit access to evidence-based treatment, it said. "Young children's mental health needs have long been overlooked," said Dr. Mary Margaret Gleason, lead author of the report. "We don't want to leave children without treatment because these are real disorders that deserve treatment, and ... Read more

Related support groups: Anxiety, Anxiety and Stress, Attention-Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder, Disruptive Mood Dysregulation Disorder, Aggressive Behavior, Executive Function Disorder

Kids With Bipolar Disorder More Likely to Abuse Drugs, Alcohol: Study

Posted 16 Sep 2016 by Drugs.com

FRIDAY, Sept. 16, 2016 – For some teens with bipolar disorder, the risk that they will abuse alcohol and drugs may increase as they get older, a new study suggests. The research included 105 young people with bipolar disorder and 98 without the illness (the "control" group). Their average age was 14 when they first enrolled in the study. Bipolar disorder causes unusual shifts in mood, energy and activity levels, and also affects the ability to carry out everyday tasks. Initially, 34 percent of the young teens with bipolar disorder also had "substance use disorder," which means they had a problem with drug or alcohol abuse. Only 4 percent of the kids in the control group abused alcohol or drugs, the study showed. In addition, the researchers found, almost one-quarter of kids with bipolar disorder smoked cigarettes, compared to just 4 percent of the comparison group. Five years after the ... Read more

Related support groups: Bipolar Disorder, Opiate Dependence, Attention-Deficit Hyperactivity Disorder (ADHD), Opiate Withdrawal, Smoking, Mania, Drug Dependence, Smoking Cessation, Oppositional Defiant Disorder, Alcohol Dependence, Substance Abuse, Alcoholism, Severe Mood Dysregulation, Cyclothymic Disorder, Toxic Reactions Incl Drug and Substance Abuse, Acute Alcohol Intoxication, Disruptive Mood Dysregulation Disorder, Executive Function Disorder

'Managing' Elderly Patients Without Powerful Antipsychotics

Posted 26 Jul 2016 by Drugs.com

MONDAY, July 25, 2016 – About 25 percent of dementia patients in U.S. nursing homes are still quieted with risky antipsychotic medications. Now, a small study suggests that managing these difficult patients, instead of medicating them, could obtain better results. "Drugs have a place, but should not be first-line treatments. They don't work well, and there are side effects," said study author Dr. Henry Brodaty, a professor of aging and mental health at the University of New South Wales in Sydney, Australia. Antipsychotic drugs such as Risperdal (risperidone), Abilify (aripiprazole) and Seroquel (quetiapine) are approved to treat serious psychiatric conditions such as bipolar disorder and schizophrenia. But in seniors, they're often used to calm aggressive or violent behavior linked to dementia. "They're basically a sedative," said Dean Hartley, director of science initiatives with the ... Read more

Related support groups: Bipolar Disorder, Seroquel, Abilify, Schizophrenia, Mania, Latuda, Zyprexa, Risperdal, Risperidone, Schizoaffective Disorder, Dementia, Geodon, Saphris, Quetiapine, Seroquel XR, Alzheimer's Disease, Olanzapine, Invega, Clozapine, Rexulti

Bipolar Diagnosis May Take Up to 6 Years

Posted 25 Jul 2016 by Drugs.com

MONDAY, July 25, 2016 – People with bipolar disorder may face a long wait from when their symptoms start to the time they get a proper diagnosis. In fact, a new study reports the average delay is six years. That lost time can result in greater frequency and severity of episodes of the psychiatric condition, the researchers said. "While some patients, particularly those who present with psychosis, probably do receive timely treatment, the diagnosis of the early phase of bipolar disorder can be difficult," study leader Matthew Large, a professor psychiatry at the University of New South Wales, Australia, said in a school news release. "This is because mental health clinicians are sometimes unable to distinguish the depressed phase of bipolar disorder from other types of depression," he added. The new research reviewed the results of 27 past studies. Those studies included more than 9,400 ... Read more

Related support groups: Depression, Bipolar Disorder, Major Depressive Disorder, Mania, Dysthymia, Severe Mood Dysregulation, Cyclothymic Disorder, Diagnosis and Investigation, Disruptive Mood Dysregulation Disorder

Mentally Ill Still Gain Illegal Possession of Guns, Study Shows

Posted 8 Jun 2016 by Drugs.com

TUESDAY, June 7, 2016 – Almost two-thirds of violent gun crime arrests among the mentally ill were people who were already legally prohibited from having a firearm, a new study from Florida reveals. And close to one-third of the suicides carried out by the mentally ill were among people who weren't legally allowed to possess a firearm, the study found. "That's a failure of the enforcement mechanism," said study lead author Jeffrey Swanson. That troubling finding reflects a problem with the criteria for identifying individuals at risk, added Swanson, a professor with Duke University School of Medicine's department of psychiatry and behavioral sciences. Mental illness causes only a small fraction of gun violence in the United States, around 3 to 5 percent, said Colleen Barry, a professor at Johns Hopkins Bloomberg School of Public Health in Baltimore. The Duke study "does bring new ... Read more

Related support groups: Depression, Bipolar Disorder, Post Traumatic Stress Disorder, Social Anxiety Disorder, Schizophrenia, Mania, Borderline Personality Disorder, Schizoaffective Disorder, Agitation, Psychosis, Agitated State, Psychiatric Disorders, Disruptive Mood Dysregulation Disorder

Lithium Beats Newer Meds for Bipolar Disorder, Study Finds

Posted 12 May 2016 by Drugs.com

THURSDAY, May 12, 2016 – Lithium outperforms newer mood stabilizers in the treatment of bipolar disorder, a new study has found. Patients taking lithium had lower rates of self-harm and unintentional injury compared to those taking other bipolar drugs, such as valproate (Depacon, Depakote), olanzapine (Zyprexa) or quetiapine (Seroquel), said lead researcher Joseph Hayes. He is a fellow of psychiatry at University College London. "This is important because people with bipolar disorder are 15 times more likely to die by suicide and six times more likely to die by accidental injury than the general population," Hayes explained. People taking one of the alternative mood stabilizers were 40 percent more likely to harm themselves compared to patients on lithium, Hayes and his colleagues found. And people on valproate or quetiapine were 32 percent to 34 percent more likely to fall victim to ... Read more

Related support groups: Depression, Bipolar Disorder, Seroquel, Major Depressive Disorder, Lithium, Mania, Zyprexa, Quetiapine, Seroquel XR, Olanzapine, Dysthymia, Symbyax, Valproic Acid, Zyprexa Zydis, Severe Mood Dysregulation, Depakene, Cyclothymic Disorder, Eskalith, Lithobid, Eskalith-CR

Brain Wiring Changes Might Help Guard Against Bipolar Disorder

Posted 6 Jan 2016 by Drugs.com

TUESDAY, Jan. 5, 2016 – Naturally occurring brain wiring changes might help prevent bipolar disorder in people who have a high genetic risk for the mental illness, a new study suggests. The discovery about these brain wiring changes could help efforts to develop better treatments for the disorder, according to Mount Sinai Hospital researchers in New York City. People with bipolar disorder experience severe swings in mood, energy and activity levels, and the ability to perform daily tasks. Genetics are a major risk factor, and people with a parent or sibling with bipolar disorder are much more likely to develop it than those with no family history of the mental illness. Researchers used functional MRI to monitor the brains of bipolar disorder patients, their siblings who did not have the illness (resilient siblings) and unrelated healthy volunteers. The bipolar disorder patients and ... Read more

Related support groups: Bipolar Disorder, Mania, Severe Mood Dysregulation, Cyclothymic Disorder, Diagnosis and Investigation, Disruptive Mood Dysregulation Disorder, Head Imaging

Omega-3 Fatty Acids May Play Role in Bipolar Disorder: Study

Posted 5 Dec 2015 by Drugs.com

FRIDAY, Dec. 4, 2015 – A small study suggests there may be a link between levels of omega-3 fatty acids and bipolar disorder. Researchers compared 27 people with bipolar disorder and 31 people without the mental illness. Those with bipolar disorder had lower levels of certain omega-3 fatty acids that can cross the blood-brain barrier, the study authors found. Omega-3 fatty acids play an important role in communication between brain cells, and fatty acids are a major player in the immune and inflammatory systems, the researchers said. "Omega-3 and omega-6 fatty acids can shift the balance of inflammation, which we think is important in bipolar disorder," study leader Erika Saunders, an associate professor and chairwoman of psychiatry at Penn State College of Medicine in College Park, Pa., said in a school news release. Foods such as fish, vegetable oils, nuts, flax seeds and flaxseed ... Read more

Related support groups: Bipolar Disorder, Mania, Dietary Supplementation, Fish Oil, Lovaza, Vitamin/Mineral Supplementation and Deficiency, Omega-3, Cyclothymic Disorder, Omacor, Omega-3 Polyunsaturated Fatty Acids, MaxEPA, Marine Lipid Concentrate, Omega 3-6-9 Complex, Restora, EPA Fish Oil, Disruptive Mood Dysregulation Disorder, Animi-3, Omega Essentials, Sea-Omega 30, Vascazen

Research Gives Clues to Why Some Benefit More From Drug for Bipolar Disorder

Posted 28 Oct 2015 by Drugs.com

WEDNESDAY, Oct. 28, 2015 – Some people with bipolar disorder do not respond as well as others to the standby drug lithium, and a new study hints at why that may be so. The research also brings scientists closer to understanding the origins of the psychiatric illness, which causes severe mood swings that include emotional highs and lows. Specifically, the brain cells of people with bipolar disorder seem to be more sensitive than brain cells of people without the mental illness, the small study suggests. "Researchers hadn't all agreed that there was a cellular cause to bipolar disorder," study senior author Rusty Gage, a professor in the genetics lab at the Salk Institute in La Jolla, Calif., said in an institute news release. "So our study is important validation that the [brain] cells of these patients really are different." Gage and his colleagues took skin cells from six people with ... Read more

Related support groups: Bipolar Disorder, Lithium, Mania, Severe Mood Dysregulation, Cyclothymic Disorder, Lithobid, Eskalith, Eskalith-CR, Disruptive Mood Dysregulation Disorder, Lithotabs, Lithonate

Relax, Parents, Your Teen's Moodiness Should Subside, Study Finds

Posted 15 Oct 2015 by Drugs.com

THURSDAY, Oct. 15, 2015 – For parents dealing with moody teens, a new study offers welcome news: Adolescents do grow out of those emotional swings. That's what Dutch researchers report after following nearly 500 teens for five years, starting at age 13. "Mood swings are greatest in early adolescence," said Dominique Maciejewski, a doctoral student at VU University Amsterdam, who led the study. "Most teens get less moody across adolescence." She advises parents to stay calm and patient, and not to panic. "Parents would be advised not to worry too much about their teenager's moodiness, as these will decline in most cases," Maciejewski said. The study also found that although "girls show more mood swings in sadness and happiness, both boys and girls show similar changes in their mood swings across adolescence." The researchers followed 474 Dutch teens, 40 percent of whom were considered ... Read more

Related support groups: Depression, Anxiety and Stress, Major Depressive Disorder, Dysthymia, Severe Mood Dysregulation, Disruptive Mood Dysregulation Disorder

Standby Drug for Adult Bipolar Disorder May Be Safe, Effective in Children

Posted 12 Oct 2015 by Drugs.com

MONDAY, Oct. 12, 2015 – A new study suggests that lithium – for years a go-to medication for adults with bipolar disorder – may be safely used in children with the condition, at least for the short term. As the researchers explained, lithium has long been the drug of choice for treating adults with bipolar disorder, which is characterized by extreme mood swings. The condition affects about 1 percent of teens and is a leading cause of disability in the teenage years. Bipolar disorder typically begins in the teens or young adulthood, the researchers noted. While lithium is a standby medication for adult patients, it has "never been rigorously studied in children," lead researcher Dr. Robert Findling, a professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine in Baltimore, said in a university news release. To try and close that research gap, ... Read more

Related support groups: Bipolar Disorder, Lithium, Mania, Severe Mood Dysregulation, Cyclothymic Disorder, Lithobid, Eskalith, Eskalith-CR, Disruptive Mood Dysregulation Disorder, Lithotabs, Lithonate

Drug May Calm Agitation in Alzheimer's Patients

Posted 22 Sep 2015 by Drugs.com

TUESDAY, Sept. 22, 2015 – A drug that combines a cough suppressant with a heart medication might offer a safer option for calming the agitation that commonly affects people with Alzheimer's disease, an early clinical trial suggests. The study, of 220 Alzheimer's patients, found that the drug – called Nuedexta – generally eased agitation symptoms over 10 weeks. And it did not worsen patients' problems with memory, thinking and judgment, researchers reported in the Sept. 22/29 issue of the Journal of the American Medical Association. As Alzheimer's disease progresses, people often go through periods of agitation that can range from restlessness and pacing to aggressive behavior like yelling, fighting and destroying objects. If those issues can be managed without medication, that's always best, said Dr. Sam Gandy, a professor of neurology and psychiatry at Mount Sinai Hospital, in New ... Read more

Related support groups: Bipolar Disorder, Seroquel, Abilify, Schizophrenia, Latuda, Zyprexa, Risperdal, Risperidone, Schizoaffective Disorder, Geodon, Saphris, Quetiapine, Seroquel XR, Alzheimer's Disease, Agitation, Olanzapine, Agitated State, Invega, Clozapine, Rexulti

Many Say Mental Health Care Is Vital, But Often Tough to Get

Posted 1 Sep 2015 by Drugs.com

TUESDAY, Sept. 1, 2015 – Although most Americans think mental health care is important, they often believe it's expensive and hard to get, a new survey shows. In questioning more than 2,000 adults, nearly 90 percent said they place equal value on mental and physical health. But one-third said mental health care is inaccessible. And 40 percent said cost is a barrier to treatment for many people, the survey found. Forty-seven percent of respondents thought they have had a mental health condition, but only 38 percent of them had received treatment. Of those who were treated, most thought it was helpful, including 82 percent who got psychotherapy and 78 percent who received medications. The survey also found that 86 percent of participants knew that mental health disorders such as depression are risk factors for suicide. Only 47 percent knew that anxiety disorders also increase suicide ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Bipolar Disorder, Panic Disorder, Anxiety and Stress, Obsessive Compulsive Disorder, Major Depressive Disorder, Attention-Deficit Hyperactivity Disorder (ADHD), Post Traumatic Stress Disorder, Social Anxiety Disorder, Schizophrenia, Mania, Paranoid Disorder, Borderline Personality Disorder, Schizoaffective Disorder, Binge Eating Disorder, Oppositional Defiant Disorder, Postpartum Depression, Agitation

First Generic Abilify Approved

Posted 29 Apr 2015 by Drugs.com

WEDNESDAY, April 29, 2015 – The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder. License to produce the drug in multiple strengths was approved for Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals, and Torrent Pharmaceuticals, the agency said in a news release. Bipolar disorder, also known as manic depression or manic-depressive illness, is a brain disorder that causes unusual moods and activities, affecting the ability to carry out day-to-day tasks. Symptoms typically include alternating periods of depression (lows) and increased activity and restlessness (highs). Schizophrenia, another brain disorder, affects about 1 percent of Americans. Symptoms typically begin in people younger than 30, and include hearing voices, believing other people ... Read more

Related support groups: Bipolar Disorder, Seroquel, Abilify, Schizophrenia, Mania, Latuda, Zyprexa, Risperdal, Risperidone, Schizoaffective Disorder, Geodon, Saphris, Quetiapine, Seroquel XR, Olanzapine, Invega, Clozapine, Aripiprazole, Clozaril, Ziprasidone

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Bipolar Disorder